The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma
Multiple myeloma (MM) is well-known for the development of drug resistance, leading to relapse. Therefore, finding novel treatment strategies remains necessary. By performing a lipidomics assay on MM patient plasma, we aimed to identify new targets. We observed a dysregulation in the sphingolipid me...
Main Authors: | Sylvia Faict, Inge Oudaert, Ludovic D’Auria, Jonas Dehairs, Ken Maes, Philip Vlummens, Kim De Veirman, Elke De Bruyne, Karel Fostier, Isabelle Vande Broek, Rik Schots, Karin Vanderkerken, Johannes V. Swinnen, Eline Menu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/12/1823 |
Similar Items
-
The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma
by: Philip Vlummens, et al.
Published: (2019-08-01) -
Dietary inulin decreases circulating ceramides by suppressing neutral sphingomyelinase expression and activity in mice
by: Pan Deng, et al.
Published: (2020-01-01) -
Ceramides and sphingomyelinases in senile plaques
by: Maï Panchal, et al.
Published: (2014-05-01) -
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
by: Siyang Yan, et al.
Published: (2019-11-01) -
Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice
by: Liansheng Zhong, et al.
Published: (2018-01-01)